| Design, synthesis and biological evaluation of imidazo [2, 1-b] thiazole and benzo [d] imidazo [2, 1-b] thiazole derivatives as Mycobacterium tuberculosis pantothenate … G Samala, PB Devi, S Saxena, N Meda, P Yogeeswari, D Sriram Bioorganic & medicinal chemistry 24 (6), 1298-1307, 2016 | 61 | 2016 |
| Design and synthesis of novel quinoline–aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors B Medapi, J Renuka, S Saxena, JP Sridevi, R Medishetti, P Kulkarni, ... Bioorganic & medicinal chemistry 23 (9), 2062-2078, 2015 | 58 | 2015 |
| Structure-Guided Design of Novel Thiazolidine Inhibitors of O-Acetyl Serine Sulfhydrylase from Mycobacterium tuberculosis O Poyraz, VU Jeankumar, S Saxena, R Schnell, M Haraldsson, ... Journal of medicinal chemistry 56 (16), 6457-6466, 2013 | 56 | 2013 |
| Development of novel tetrahydrothieno [2, 3-c] pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known … G Samala, PB Devi, R Nallangi, JP Sridevi, S Saxena, P Yogeeswari, ... Bioorganic & medicinal chemistry 22 (6), 1938-1947, 2014 | 46 | 2014 |
| Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular … S Saxena, M Abdullah, D Sriram, L Guruprasad Journal of Biomolecular Structure and Dynamics 36 (12), 3184-3198, 2018 | 44 | 2018 |
| Identification of novel inhibitors against Mycobacterium tuberculosis L-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening S Saxena, PB Devi, V Soni, P Yogeeswari, D Sriram Journal of Molecular Graphics and Modelling 47, 37-43, 2014 | 42 | 2014 |
| Homology modeling, docking and structure-based virtual screening for new inhibitor identification of Klebsiella pneumoniae heptosyltransferase-III SK Panda, S Saxena, L Guruprasad Journal of Biomolecular Structure and Dynamics, 2019 | 39 | 2019 |
| Discovery of novel inhibitors targeting the Mycobacterium tuberculosis O-acetylserine sulfhydrylase (CysK1) using virtual high-throughput screening Ö Poyraz, S Saxena, R Schnell, P Yogeeswari, G Schneider, D Sriram Bioorganic & medicinal chemistry letters 23 (5), 1182-1186, 2013 | 39 | 2013 |
| Mycobacterium tuberculosis lysine-ɛ-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors DS Rudraraju Srilakshmi Reshma, Variam Ullas Jeankumar, Nidhi Kapoor ... Bioorganic & Medicinal Chemistry, 2017 | 35 | 2017 |
| Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitors S Saxena, G Samala, JP Sridevi, PB Devi, P Yogeeswari, D Sriram European Journal of Medicinal Chemistry 92, 401-414, 2015 | 35 | 2015 |
| Identification and development of 2-methylimidazo [1, 2-a] pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors G Samala, R Nallangi, PB Devi, S Saxena, R Yadav, JP Sridevi, ... Bioorganic & Medicinal Chemistry 22 (15), 4223-4232, 2014 | 35 | 2014 |
| Engineering another class of anti-tubercular lead: Hit to lead optimization of an intriguing class of gyrase ATPase inhibitors VU Jeankumar, RS Reshma, R Vats, R Janupally, S Saxena, ... European Journal of Medicinal Chemistry 122, 216-231, 2016 | 33 | 2016 |
| Structure‐Guided Design of Thiazolidine Derivatives as Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors PB Devi, G Samala, JP Sridevi, S Saxena, M Alvala, EG Salina, D Sriram, ... ChemMedChem 9 (11), 2538-2547, 2014 | 31 | 2014 |
| Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium … S Saxena, L Durgam, L Guruprasad Journal of Biomolecular Structure and Dynamics 37 (7), 1783-1799, 2019 | 30 | 2019 |
| Pharmacophore-based virtual screening and docking studies on Hsp90 inhibitors S Saxena, SS Chaudhaery, K Varshney, AK Saxena SAR and QSAR in Environmental Research 21 (5-6), 445-462, 2010 | 30 | 2010 |
| Development of 2-(4-oxoquinazolin-3 (4H)-yl) acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis GS Pedgaonkar, JP Sridevi, VU Jeankumar, S Saxena, PB Devi, ... European journal of medicinal chemistry 86, 613-627, 2014 | 29 | 2014 |
| Enabling the (3+ 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure … VU Jeankumar, RS Reshma, R Janupally, S Saxena, JP Sridevi, ... Organic & Biomolecular Chemistry 13 (8), 2423-2431, 2015 | 25 | 2015 |
| Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain S Saxena, G Samala, J Renuka, JP Sridevi, P Yogeeswari, D Sriram Bioorganic & medicinal chemistry 23 (7), 1402-1412, 2015 | 24 | 2015 |
| Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydratase GO Petersen, S Saxena, J Renuka, V Soni, P Yogeeswari, DS Santos, ... Journal of Molecular Graphics and Modelling 60, 124-131, 2015 | 21 | 2015 |
| Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities PB Devi, S Jogula, AP Reddy, S Saxena, JP Sridevi, D Sriram, ... Molecular Informatics 34 (2‐3), 147-159, 2015 | 17 | 2015 |
D SriramSenior Professor, Department of Pharmacy, BITS-Pilani, Hyderabad CampusVerified email at hyderabad.bits-pilani.ac.in
